Onco360

Onco360, the largest independent provider of Oncology Pharmacy Services in the U.S., announced today that Bill Gittinger has joined the organization as a National Director for its Managed Care business. Mr.

Onco360, the largest independent provider of Oncology Pharmacy Services in the U.S., announced today the appointment of Kirby Eng, R.Ph to the position of Executive Director, Clinical Oncology Management Services.   In this role, Mr.

Both Limited Distribution Products Immediately Available Via Onco360®

Newly Approved Chronic Lymphocytic Leukemia Drug Available Immediately

Newly Approved Drug Immediately Available For Order Through Onco360

MedImpact Healthcare Systems, Inc., the nation’s largest privately held provider of pharmacy benefit management (PBM) services, and Onco360, the fastest-growing independent Oncology Pharmacy and Clinical Support Services company, today announced a...

New York, NY - On September 30, 2013, the FDA granted Perjeta (pertuzumab) accelerated approval as part of a complete treatment regimen for patients with early stage breast cancer before surgery (neoadjuvant setting).

New York – For the second straight year, Onco360 has been named to the prestigious Inc. 500|5000 list of fastest-growing private companies in America.  Onco360 is the number one, New York State healthcare company on the list by revenue.

Media Contact:  Amvrosios Ioannidis Onco360® P:  646-356-7705 M: 516-492-2557 E: amvrosiosi@Onco360.com Tarceva® (erlotinib) Now Only Available Through Limited Distribution: Onco360® Selected as a Network Pharmacy Provider; Patient Transfer...

Media Contact:  Amvrosios Ioannidis Onco360® P:  646-356-7705 M: 516-492-2557 E: amvrosiosi@Onco360.com Now Available Through Onco360®: Two Newly Approved Limited Distribution Oncology Drugs The FDA recently announced the approval of two new...